REGISTER LOGIN

Lawyers Zeynep Çağla Üstün

Zeynep Çağla Üstün

Zeynep Çağla Üstün

Gün + Partners
[email protected]
BIOGRAPHY
INSIGHTS

Practice Areas & Work Department

Intellectual Property

Patent and Utility Models

Life Sciences

Trademarks and Designs


Languages

English

Turkish


Memberships

Ankara Bar Association

Ankara Bar Association FMR Law Board

Biyobenzer İlaçlar ve Patent Tecavüzü Karinesi

Jeneriklere karşı patent haklarının ileri sürülmesi için açılabilecek davaların öncesinde patent hakkı sahibi esasen karanlıkta ilerler. Çünkü özellikle jenerik ilacın kısa ürün bilgisinin henüz yayınlanmadığı veya patentin ihlal edilip edilmediğinin kısa ürün bilgisinde yer alan sınırlı bilgilerle anlaşılamadığı durumlarda ...
Selin Sinem Erciyas
Aysel Korkmaz Yatkın
Zeynep Çağla Üstün
Beste Turan
22.10.2024

Applying Presumption of Patent Infingement Against Biosimilars

Before filing lawsuits to assert patent rights against generics or biosimilars, the patent holder essentially operates in the dark.
Selin Sinem Erciyas
Aysel Korkmaz Yatkın
Zeynep Çağla Üstün
24.09.2024

Implementation of Discovery of Evidence in Patent Law

One of the most important temporary protection measures regulated by Turkish law is the determination of evidence.
Selin Sinem Erciyas
Aysel Korkmaz Yatkın
Zeynep Çağla Üstün
Beste Turan
29.08.2024

Kısmi İhtiyati Tedbir Kararı ile Orijinal İlacın Fiyat Düşüşünün Önlenmesi

Kanunlar ve uluslararası sözleşmeler ile kendilerine tanınmış patent haklarından yararlanmak isteyen ilaç patenti sahiplerinin, bu haklarından sağlıklı bir şekilde yararlanabilmeleri için doğru stratejiyi belirleyerek doğru zamanda doğru adımları atmaları büyük önem arz etmektedir. Zira Sınai Mülkiyet Kanunumuz ile ilaçların ruhsatlandırılması ve bunun için gerekli test ve deneyler de dâhil olmak üzere, patent konusu buluşu içeren deneme amaçlı fiiller patent hakkının istisnalarından bir tanesi olarak düzenlenmiştir.
Selin Sinem Erciyas
Zeynep Çağla Üstün
Beste Turan
29.01.2024

Preventing Price Decreases of Original Pharmaceutical Products with Partial Preliminary Injunctions

Taking the right steps at the right time, with the most appropriate strategy, is significantly important for patent owners of pharmaceutical products wishing to benefit from the related rights granted to them by the laws and international conventions. Indeed, the Turkish Industrial Property Code regulates the exception of patent rights concerning experimental acts in regard to the product subject to the invention, as well as marketing authorization, and the necessary testing and experiments within its scope.
Selin Sinem Erciyas
Zeynep Çağla Üstün
Beste Turan
23.01.2024

Turning the Turkish Tide on Rising Tactical Patent Invalidation Actions

Filing patent invalidation actions for tactical purposes such as jeopardising patent infringement actions of patent owners and gaining time by complicating the infringement proceedings has become a common strategy of infringers in recent years. This strategy may cause the patent owner to suffer due to the inability to use its patent properly during the limited protection period of 20 years, even if the invalidity claims do not have a solid basis and they are filed on a ‘try your luck’ basis.
Selin Sinem Erciyas
Zeynep Çağla Üstün
Aysu Eryaşar
07.12.2023

An In-Depth Analysis of Inventorship of AI and Türkiye’s Position

“In recent legal debates, the patentability of AI-generated inventions has been contentious. Historically, only humans were considered inventors, anchored in notions of personhood and intellect. Yet, in a bold move, South Africa and Australia's Federal Court recognised AI, specifically DABUS, as a potential inventor in 2021, defying conventional views. Proponents argue that this accommodates modern innovation trends, while sceptics raise concerns about ownership rights, potential inundation of trivial patents, and diminished human oversight. With patent laws varying globally, the landscape remains dynamic. As AI's role in R&D grows, more countries could re-evaluate their stances, reshaping the intellectual property (IP) sphere.”
Selin Sinem Erciyas
Zeynep Çağla Üstün
27.09.2023

Unified Patent Court - How It Will Resonate in Turkey?

The concept of the Unified Patent Court entered the lives of European Patent holders with the UPC Agreement, an international agreement dated February 19, 2013.
Selin Sinem Erciyas
Aysel Korkmaz Yatkın
Zeynep Çağla Üstün
Aysu Eryaşar
04.04.2023
Load More
Ready to stay ahead of the curve?
Share your interest anonymously and let us guide you through the informative articles on the hottest legal topics.
|
Successful Your message has been sent